AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EBOS GROUP LIMITED

21.090

-0.320-1.49%

Volume:72.87K

Turnover:1.54M

Market Cap:4.32B

PE:19.35

High:21.330

Open:21.110

Low:20.800

Close:21.410

52wk High:37.582

52wk Low:20.800

Shares:205.02M

Float Shares:164.12M

Volume Ratio:0.90

T/O Rate:0.04%

Dividend:1.08

Dividend Rate:5.14%

EPS(TTM):1.090

EPS(LYR):1.090

ROE:8.39%

ROA:3.78%

PB:1.58

PE(LYR):19.35

Loading ...

Overview Company News Filings

ASX Biggest Losers

MT Newswires Live

EBOS Group Ltd-NZX Capital Change Notice

THOMSON REUTERS

ASX Biggest Losers

MT Newswires Live

EBOS Group Ltd-NZX Performance Rights Update

THOMSON REUTERS

EBOS Group Ltd-NZX Performance Rights Update

THOMSON REUTERS

Large Caps Could Be Ready to Return to New Zealand in 2026 -- Market Talk

NZX Midday Sector Update: Health Technology Advances, Consumer Durables Decline

MT Newswires Live

EBOS Group Ltd-NZX Performance Rights Update

THOMSON REUTERS

Ebos Group Reaffirms Fiscal 2026 Underlying EBITDA Guidance

MT Newswires Live

Ebos Group Opens New Pharmacy Distribution Center in Western Sydney

MT Newswires Live

EBOS Group Ltd-EBOS Announces Opening of New Site in Western Sydney

THOMSON REUTERS

Algorae Pharmaceuticals Expands Commercial Footprint with New Cadila Partnership

Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk

Ebos Shakes Bear Following Post-Results Selloff -- Market Talk

Ebos's Near-Term Earnings Outlook Dims -- Market Talk

EBOS Group to Join ASX 200 Index

MT Newswires Live

EBOS Loses Bull Following Soft Annual Result -- Market Talk

NZX Midday Sector Update: Energy Minerals Advance, Health Technology Declines

MT Newswires Live

EBOS Group Posts Lower Fiscal 2025 Underlying Earnings, Revenue

MT Newswires Live

BRIEF-EBOS Group Sees Underlying EBITDA Of A$615 – 635 Mln in FY26

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EBO.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EBO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EBO.AU\",,,,,undefined,":{"symbol":"EBO.AU","market":"AU","secType":"STK","nameCN":"EBOS GROUP LIMITED","latestPrice":21.09,"timestamp":1770873120000,"preClose":21.41,"halted":0,"volume":72869,"delay":0,"changeRate":-0.01494628678187764,"nameEN":"EBOS GROUP LIMITED","floatShares":164124117,"shares":205019637,"eps":1.09,"marketStatus":"Not Yet Opened","change":-0.32,"latestTime":"02-12 16:12:00 AEDT","open":21.11,"high":21.33,"low":20.8,"amount":1539884,"amplitude":0.024755,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.09,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770937200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":21.41,"dividendRate":0.051351,"openAndCloseTimeList":[[1770850800000,1770872400000]],"volumeRatio":0.9043646396122039,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EBO.AU\",,,,,undefined,":{"symbol":"EBO.AU","floatShares":164124117,"roa":"3.78%","roe":"8.39%","lyrEps":1.09,"volumeRatio":0.9043646396122039,"shares":205019637,"dividePrice":1.083,"high":21.33,"amplitude":0.024755,"preClose":21.41,"low":20.8,"week52Low":20.8,"pbRate":"1.58","psRate":"0.35","week52High":37.582,"institutionHeld":0,"latestPrice":21.09,"eps":1.09,"divideRate":0.051351,"volume":72869,"delay":0,"ttmEps":1.09,"open":21.11,"prevYearClose":23.64,"prevWeekClose":21.41,"prevMonthClose":22.1,"prevQuarterClose":23.64,"fiveDayClose":22.15,"twentyDayClose":22.54,"sixtyDayClose":25.06,"dividendPayoutRate":1.0283624229793926,"dividendGrowthYears":2,"dividendGrowthRate":0.020071382594797148,"fiveYearAvgDividendRate":0.028634014092226722},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EBO.AU\",params:#limit:5,,,undefined,":[{"date":"2025-09-04","symbol":"EBO.AU","amount":0.4919,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-05","defaultRemindTime":1756944000000,"name":"EBOS GROUP LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-05","currency":"AUD","dateTimestamp":1756908000000,"payDate":"2025-09-24"},{"date":"2025-02-27","symbol":"EBO.AU","amount":0.45443,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-28","name":"EBOS GROUP LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-02-28","currency":"AUD","dateTimestamp":1740574800000,"payDate":"2025-03-21"},{"date":"2024-08-29","symbol":"EBO.AU","amount":0.56602,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-08-30","defaultRemindTime":1724889600000,"name":"EBOS GROUP LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-18","payableDate":"2024-08-30","currency":"AUD","dateTimestamp":1724853600000,"payDate":"2024-09-18"},{"date":"2024-02-29","symbol":"EBO.AU","amount":0.47558,"announcedDate":"2024-02-21","type":"dividend","market":"AU","newRecordDate":"2024-03-01","defaultRemindTime":1709161200000,"name":"EBOS","recordDate":"2024-03-22","payableDate":"2024-03-01","currency":"AUD","dateTimestamp":1709125200000,"payDate":"2024-03-22"},{"date":"2023-09-07","symbol":"EBO.AU","amount":0.57,"announcedDate":"2023-08-23","type":"dividend","market":"AU","newRecordDate":"2023-09-08","defaultRemindTime":1694044800000,"name":"EBOS","recordDate":"2023-09-29","payableDate":"2023-09-08","currency":"NZD","dateTimestamp":1694008800000,"payDate":"2023-09-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EBO.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-24","recordDate":"2020-09-25","paymentDate":"2020-10-09","value":0.017647,"currency":"NZD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-18","value":0.01875,"currency":"NZD"},{"executeDate":"2021-09-09","recordDate":"2021-09-10","paymentDate":"2021-09-24","value":0.0202941,"currency":"NZD"},{"executeDate":"2022-03-03","recordDate":"2022-03-04","paymentDate":"2022-03-18","value":0.0207352,"currency":"NZD"},{"executeDate":"2022-09-08","recordDate":"2022-09-09","paymentDate":"2022-09-30","value":0.0216176,"currency":"NZD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EBO.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608438628","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2608438628","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608438628?lang=en_us&edition=fundamental","pubTime":"2026-02-03 11:20","pubTimestamp":1770088812,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest losses on Tuesday.Contact Energy : -5%, AU$8.06Ventia Services Group : -4%, AU$5.55Telix Pharmaceuticals : -3%, AU$10.14Ebos Group : -2%, AU$21.9Mineral Resources : -2%, AU$55.24Meridian Energy : -2%, AU$4.83ARB : -2%, AU$25.81Abacus Storage King : -2%, AU$1.53Virgin Australia Holdings : -2%, AU$3.1Summerset Group Holdings  : -1%, AU$10","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASK.AU","BK7055","MEZ.AU","BK7095","BK7151","BK7030","TLX.AU","ARB.AU","VNT.AU","BK7113","BK7006","BK7067","EBO.AU","BK7103","SNZ.AU","BK7507","BK7060","CEN.AU","BK7051","VGN.AU","MIN.AU","BK7504"],"gpt_icon":0},{"id":"2604159862","title":"EBOS Group Ltd-NZX Capital Change Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2604159862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604159862?lang=en_us&edition=fundamental","pubTime":"2026-01-20 07:27","pubTimestamp":1768865223,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nTUE71W6SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBO.AU","BK7103"],"gpt_icon":0},{"id":"2603709578","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2603709578","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603709578?lang=en_us&edition=fundamental","pubTime":"2026-01-13 09:37","pubTimestamp":1768268276,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Tuesday.GQG Partners : -6%, AU$1.68Zip : -5%, AU$3.355Viva Energy Group : -4%, AU$1.982Endeavour Group : -4%, AU$3.66Mesoblast : -4%, AU$2.745Ampol : -3%, AU$30.19Life360 : -2%, AU$30.88EBOS Group : -2%, AU$22.99Block : -2%, AU$104.54Super Retail Group : -2%, AU$14.65","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","MSB.AU","BK7040","BK7158","BK7065","360.AU","XYZ.AU","ZIP.AU","BK7508","GQG.AU","BK7128","ALD.AU","BK7501","BK7062","BK7093","BK7103","SUL.AU","VEA.AU","EDV.AU","BK7016","EBO.AU"],"gpt_icon":0},{"id":"2601707890","title":"EBOS Group Ltd-NZX Performance Rights Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2601707890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601707890?lang=en_us&edition=fundamental","pubTime":"2026-01-05 08:24","pubTimestamp":1767572667,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUE919NBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7103","EBO.AU"],"gpt_icon":0},{"id":"2588704564","title":"EBOS Group Ltd-NZX Performance Rights Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2588704564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588704564?lang=en_us&edition=fundamental","pubTime":"2025-12-02 08:22","pubTimestamp":1764634942,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUE6LQDC8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7103","EBO.AU"],"gpt_icon":0},{"id":"2588719638","title":"Large Caps Could Be Ready to Return to New Zealand in 2026 -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2588719638","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588719638?lang=en_us&edition=fundamental","pubTime":"2025-12-01 08:13","pubTimestamp":1764547980,"startTime":"0","endTime":"0","summary":"0013 GMT - A top theme for New Zealand's equity market in 2026: The return of the large caps. That is the view of Forsyth Barr, which says it is entering 2026 with a strong sense of optimism as New Zealand's economy recovers. In New Zealand this year, mid-cap stocks had their strongest relative performance to large caps since 2006, analyst Matt Montgomerie says. And that script could flip. \"We currently have the lowest estimated total return spread between large caps and mid/small caps for the last decade,\" Forsyth Barr says. Its top five stocks for 2026 are SkyCity Entertainment, Oceania Healthcare, Mainfreight, Ebos, and Port of Tauranga. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK8050","EBO.NZ","BK7078","BK7103","NZ50G.NZ","BK8046","BK8036","OCA.NZ","SKC.AU","MFGHF","NZ20C.NZ","SKC.NZ","POT.NZ","BK4131","T10G.NZ","EBO.AU","BK8037"],"gpt_icon":0},{"id":"2579154573","title":"NZX Midday Sector Update: Health Technology Advances, Consumer Durables Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2579154573","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579154573?lang=en_us&edition=fundamental","pubTime":"2025-10-30 09:02","pubTimestamp":1761786137,"startTime":"0","endTime":"0","summary":"Health technology shares gained the most on New Zealand's Exchange, rising past 1% by midday Thursday.Shares of Ebos Group  rose nearly 2% in recent trade.The company on Wednesday reaffirmed its fiscal year 2026 underlying earnings before interest, taxes, depreciation, and amortization guidance of AU$615 million to AU$635 million, skewed to the second half of the year.Meanwhile, the consumer durables sector fell past 3%.KMD Brands  was down past 3% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZX.NZ","BK7128","T10G.NZ","BK7103","NZ20C.NZ","EBO.AU","KMD.AU","BK8020","NZ50G.NZ"],"gpt_icon":0},{"id":"2579374156","title":"EBOS Group Ltd-NZX Performance Rights Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2579374156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579374156?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:01","pubTimestamp":1761782505,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE5WLC2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBO.AU","BK7103"],"gpt_icon":0},{"id":"2579372918","title":"Ebos Group Reaffirms Fiscal 2026 Underlying EBITDA Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2579372918","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579372918?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:26","pubTimestamp":1761686816,"startTime":"0","endTime":"0","summary":"Ebos Group (ASX:EBO, NZE:EBO) reaffirmed its fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization guidance of AU$615 million to AU$635 million, skewed to the second half of the year, according to a Wednesday filing with the Australian and New Zealand bourses.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7103","XKO.AU","EBO.NZ","XAO.AU","BK8046","XJO.AU","EBO.AU"],"gpt_icon":0},{"id":"2578323671","title":"Ebos Group Opens New Pharmacy Distribution Center in Western Sydney","url":"https://stock-news.laohu8.com/highlight/detail?id=2578323671","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578323671?lang=en_us&edition=fundamental","pubTime":"2025-10-28 05:36","pubTimestamp":1761600974,"startTime":"0","endTime":"0","summary":"Ebos Group  opened its new Symbion pharmacy wholesale distribution center in Kemps Creek, Sydney, the sixth site in its AU$360 million distribution center renewal program, according to a Tuesday filing with the New Zealand and Australian bourses.The Kemps Creek center serves 1,500 New South Wales customers, with capacity to expand, and features on-site energy generation via a 1.8-megawatt solar array, three 706-kilowatt  bio-diesel generators, and a 669 kW battery, the filing said.The old Sydney center is set to close by fiscal 2026.The company expects a 30% reduction in annual capital expenditure following the completion of the renewal program in 2026, with only two sites remaining, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WRN","EBO.NZ","BK8046","BK4168","EBO.AU","BK7103"],"gpt_icon":0},{"id":"2578459675","title":"EBOS Group Ltd-EBOS Announces Opening of New Site in Western Sydney","url":"https://stock-news.laohu8.com/highlight/detail?id=2578459675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578459675?lang=en_us&edition=fundamental","pubTime":"2025-10-28 04:35","pubTimestamp":1761597347,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUE4S3JXX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7103","EBO.AU"],"gpt_icon":0},{"id":"2576600257","title":"Algorae Pharmaceuticals Expands Commercial Footprint with New Cadila Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2576600257","media":"Small Caps","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576600257?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:56","pubTimestamp":1760918195,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals and private Indian company Cadila Pharmaceuticals have entered into a licence and supply agreement covering two new generic medicines for the Australian and New Zealand markets.The agreement will formalise an operational framework for the partnership and will see Algorae commence planning for Therapeutic Goods Administration  registration to enable commercialisation of the products, which will target key therapeutic areas including cardiovascular and metabolic disorders.Cadila operates manufacturing facilities in the US, UK, European Union, and Australia, and its products are distributed in over 100 countries, supported by a workforce of more than 9,000 professionals and a research and development division comprising more than 350 scientists.Algorae chief commercial officer Vishal Shah said the agreement would expand Algorae’s commercial footprint into new regions.“This deal represents an important step in executing our commercial strategy and expanding our prod","market":"nz","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Expands-Commercial-Footprint-Cadila-Partnership.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Expands-Commercial-Footprint-Cadila-Partnership.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/algorae-pharmaceuticals-expands-commercial-footprint-new-cadila-partnership/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/algorae-pharmaceuticals-expands-commercial-footprint-new-cadila-partnership/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["1AI.AU","BK7001","XKO.AU","XJO.AU","BK7067","XAO.AU","BK7103","EBO.AU","TGA","TGA.AU","BK4213"],"gpt_icon":0},{"id":"2570707053","title":"Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2570707053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570707053?lang=en_us&edition=fundamental","pubTime":"2025-09-25 10:02","pubTimestamp":1758765720,"startTime":"0","endTime":"0","summary":"0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBO.AU","BK7103","EBO.NZ","BK8046"],"gpt_icon":0},{"id":"2568287109","title":"Ebos Shakes Bear Following Post-Results Selloff -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2568287109","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568287109?lang=en_us&edition=fundamental","pubTime":"2025-09-19 09:00","pubTimestamp":1758243600,"startTime":"0","endTime":"0","summary":"0100 GMT - Pharmaceutical supplier Ebos shakes its bear at Citi following the recent sharp selloff in its stock. With the stock down by more than 25% since the dual-listed company reported its annual results on Aug. 27, the investment bank raises its recommendation to neutral from sell. Analyst Laura Sutcliffe says shares are now trading at about 17 times estimated FY 2027 core earnings, which is close to their historical average. She sets her target price a little lower to reflect the softer-than-expected margins reported last month. Citi cuts its target price on Ebos's Australia-listed stock by 12.5% to A$28.00. Shares are up 3.0% at A$26.15. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","EBO.NZ","POST","BK8046","BK7103","EBO.AU"],"gpt_icon":0},{"id":"2566300436","title":"Ebos's Near-Term Earnings Outlook Dims -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2566300436","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566300436?lang=en_us&edition=fundamental","pubTime":"2025-09-09 06:23","pubTimestamp":1757370180,"startTime":"0","endTime":"0","summary":"2223 GMT - Pharmacy group Ebos's annual earnings guidance of A$615 million-A$635 million was weaker than expected. It's also entering FY26 with a new CEO. \"This coupled with a step-up in depreciation and amortization  and net interest  drives a reset our near-term forecasts,\" analyst Tom Godfrey says. Ord Minnett cuts its Ebitda forecast by 7%, to A$627 million, with a larger 18% reduction in net profit, to A$267 million. Its price target falls 13%, to A$33.00/share, as a result. Still, Ord Minnett retains an \"accumulate\" call on Ebos. \"Looking ahead, we continue to view Ebos as a quality operator, with consistent growth strategies and a strong capital allocation track record,\" it says. \"This underpins improving EPS growth medium term.\" ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBO.AU","EBO.NZ"],"gpt_icon":0},{"id":"2565574343","title":"EBOS Group to Join ASX 200 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2565574343","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565574343?lang=en_us&edition=fundamental","pubTime":"2025-09-08 11:16","pubTimestamp":1757301385,"startTime":"0","endTime":"0","summary":"EBOS Group (ASX:EBO, NZE:EBO) said it will be added to the S&P/ASX 200 Index with effect from Sept. 22, according to Monday filings with the Australian and New Zealand bourses.The company's Australian shares rose almost 1% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7103","EBO.AU","XAO.AU","XJO.AU","XKO.AU"],"gpt_icon":0},{"id":"2562777296","title":"EBOS Loses Bull Following Soft Annual Result -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2562777296","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562777296?lang=en_us&edition=fundamental","pubTime":"2025-08-28 08:44","pubTimestamp":1756341840,"startTime":"0","endTime":"0","summary":"0044 GMT - Pharmacy group Ebos's disappointing FY 2025 result costs it a bull. Forsyth Barr downgrades Ebos to neutral from outperform, and cuts its price target by 19% to NZ$37.25 after making material reductions to its earnings forecasts and projecting higher capex. Analyst Matt Montgomerie says the drivers of Ebos's softer-than-expected result and outlook commentary don't appear to be structural. Forsyth Barr still sees Ebos as positioned for medium-term growth. \"But at 23x our revised 12-month forward EPS with a high single-digit three-year forward EPS compound annual growth rate, we don't see valuation upside to retain outperform,\" Forsyth Barr says. Ebos is down 5.5% at NZ$32.00. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK8046","EBO.NZ","BK7103","EBO.AU"],"gpt_icon":0},{"id":"2562076798","title":"NZX Midday Sector Update: Energy Minerals Advance, Health Technology Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2562076798","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562076798?lang=en_us&edition=fundamental","pubTime":"2025-08-27 09:53","pubTimestamp":1756259620,"startTime":"0","endTime":"0","summary":"Energy minerals shares gained the most on New Zealand's Exchange, rising 4% by midday Wednesday.Channel Infrastructure NZ  gained 4% in recent trade.Meanwhile, the health technology sector fell almost 3%.Ebos Group  was down nearly 14% in recent trade.The company on Wednesday reported fiscal 2025 underlying earnings of AU$1.313 per share, down from AU$1.579 a year earlier. Revenue for the 12 months ended June 30 was AU$12.27 billion, compared with AU$13.19 billion a year earlier.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTX","NZ20C.NZ","BK8020","T10G.NZ","BK7103","BK4109","NZ50G.NZ","NZX.NZ","EBO.AU"],"gpt_icon":0},{"id":"2562750401","title":"EBOS Group Posts Lower Fiscal 2025 Underlying Earnings, Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2562750401","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562750401?lang=en_us&edition=fundamental","pubTime":"2025-08-27 05:25","pubTimestamp":1756243509,"startTime":"0","endTime":"0","summary":"EBOS Group  reported Wednesday fiscal 2025 underlying earnings of AU$1.313 per share, down from AU$1.579 a year earlier.Analysts polled by FactSet expected earnings of AU$1.40.Revenue for the 12 months ended June 30 was AU$12.27 billion, compared with AU$13.19 billion a year earlier. Analysts surveyed by FactSet expected AU$12.17 billion.The company expects to deliver an underlying earnings before interest, taxes, depreciation, and amortization of AU$615 million to AU$635 million in fiscal 2026.The board declared a final dividend of NZ$0.615 per share, unchanged from the previous year, payable Sept. 24 to shareholders on record as of Sept. 5.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EBO.AU"],"gpt_icon":0},{"id":"2562757668","title":"BRIEF-EBOS Group Sees Underlying EBITDA Of A$615 – 635 Mln in FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2562757668","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562757668?lang=en_us&edition=fundamental","pubTime":"2025-08-27 04:36","pubTimestamp":1756240579,"startTime":"0","endTime":"0","summary":"BRIEF-EBOS Group Sees Underlying EBITDA Of A$615 – 635 Mln in FY26Aug 27  - EBOS Group Ltd EBO.AX:IN FY26, GROUP TARGETING UNDERLYING EBITDA OF A$615 – 635 MILLIONIN FY26, EXPECT CAPITAL EXPENDITURE OF A$130 – 140 MILLIONFY ADJUSTED NET INCOME AUD 258 MILLIONFY REVENUE AUD 12,267 MILLIONFINAL DIVIDEND OF NZ 61.5 CENTS PER SHAREFurther company coverage: EBO.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nFWN3UI0V7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBO.AU","BK7103"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}